Acceleron Pharma - Stock Price History | XLRN

Historical daily share price chart and data for Acceleron Pharma since 2021 adjusted for splits. The latest closing stock price for Acceleron Pharma as of September 27, 2021 is 178.87.
  • The all-time high Acceleron Pharma stock closing price was 178.87 on September 27, 2021.
  • The Acceleron Pharma 52-week high stock price is 182.44, which is 2% above the current share price.
  • The Acceleron Pharma 52-week low stock price is 99.98, which is 44.1% below the current share price.
  • The average Acceleron Pharma stock price for the last 52 weeks is 125.13.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Acceleron Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 97.8957 52.6100 134.9500 50.9500 127.9400 141.31%
2019 43.5772 44.0900 53.3400 37.5200 53.0200 21.75%
2018 44.4942 42.6600 58.4700 33.6200 43.5500 2.62%
2017 31.9099 25.4750 43.2900 23.3000 42.4400 66.30%
2016 31.6301 44.8600 44.8600 23.6400 25.5200 -47.66%
2015 34.4651 38.2600 50.0400 22.0500 48.7600 25.15%
2014 35.2886 38.1100 56.7000 24.2100 38.9600 -1.62%
2013 23.8501 19.9900 39.6000 17.4000 39.6000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.893B $0.093B
Acceleron Pharma Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. Acceleron Pharma Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29